Literature DB >> 10597313

Negative regulation of Par-4 by oncogenic Ras is essential for cellular transformation.

S G Qiu1, S Krishnan, N el-Guendy, V M Rangnekar.   

Abstract

Oncogenic variants of the cellular Ras protein are often associated with different types of human cancers. However, the mechanisms by which oncogenic Ras induces transformation are not fully established. Expression of the transcriptional repressor Par-4 was down-regulated by oncogenic Ras via the Raf-MEK-ERK pathway. Restoration of Par-4 levels by abrogation of the Raf-MEK-ERK pathway with the MEK-inhibitor PD98059 or by ectopic Par-4, that acted to inhibit ERK expression and activation, was sufficient to suppress oncogenic Ras-induced transformation. These findings identify Par-4 as a novel target that has to be down-modulated by oncogenic Ras for successful transformation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10597313     DOI: 10.1038/sj.onc.1203199

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  16 in total

1.  pH-induced folding of an apoptotic coiled coil.

Authors:  K Dutta; A Alexandrov; H Huang; S M Pascal
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

Review 2.  Cancer-selective apoptotic effects of extracellular and intracellular Par-4.

Authors:  T Shrestha-Bhattarai; V M Rangnekar
Journal:  Oncogene       Date:  2010-05-03       Impact factor: 9.867

3.  Par-4 binds to topoisomerase 1 and attenuates its DNA relaxation activity.

Authors:  Anindya Goswami; Shirley Qiu; Thomas S Dexheimer; Padhma Ranganathan; Ravshan Burikhanov; Yves Pommier; Vivek M Rangnekar
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

4.  Phosphorylation of Par-4 by protein kinase A is critical for apoptosis.

Authors:  Sushma Gurumurthy; Anindya Goswami; Krishna Murthi Vasudevan; Vivek M Rangnekar
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

5.  Clinical significance of GADD153 expression in stage I non-small cell lung cancer.

Authors:  Chang Youl Lee; Myung Goo Lee; Kyung Chan Choi; Hee Mo Kang; Yoon Soo Chang
Journal:  Oncol Lett       Date:  2012-06-21       Impact factor: 2.967

Review 6.  Mechanisms of apoptosis by the tumor suppressor Par-4.

Authors:  Nikhil Hebbar; Chi Wang; Vivek M Rangnekar
Journal:  J Cell Physiol       Date:  2012-12       Impact factor: 6.384

7.  The Akt inhibitor ISC-4 activates prostate apoptosis response protein-4 and reduces colon tumor growth in a nude mouse model.

Authors:  Arun K Sharma; Christina L Kline; Arthur Berg; Shantu Amin; Rosalyn B Irby
Journal:  Clin Cancer Res       Date:  2011-05-09       Impact factor: 12.531

Review 8.  A journey beyond apoptosis: new enigma of controlling metastasis by pro-apoptotic Par-4.

Authors:  Reyaz Ur Rasool; Debasis Nayak; Souneek Chakraborty; Archana Katoch; Mir Mohd Faheem; Hina Amin; Anindya Goswami
Journal:  Clin Exp Metastasis       Date:  2016-08-27       Impact factor: 5.150

9.  Prostate apoptosis response protein 4 sensitizes human colon cancer cells to chemotherapeutic 5-FU through mediation of an NF kappaB and microRNA network.

Authors:  Bi-Dar Wang; Christina Leah B Kline; Danielle M Pastor; Thomas L Olson; Bryan Frank; Truong Luu; Arun K Sharma; Gavin Robertson; Matthew T Weirauch; Steven R Patierno; Joshua M Stuart; Rosalyn B Irby; Norman H Lee
Journal:  Mol Cancer       Date:  2010-04-30       Impact factor: 27.401

10.  Suppression of PTEN expression by NF-kappa B prevents apoptosis.

Authors:  Krishna Murthi Vasudevan; Sushma Gurumurthy; Vivek M Rangnekar
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.